Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis.


The objective of this work was to estimate the accuracy of mesothelin as a biomarker for ovarian cancer. A quantitative systematic review was performed. A comprehensive search of the Medline, LILACS, SCOPUS, Embase, Cochrane Central Register of Controlled Trials, Biomed Central, and ISI Web of Science databases was conducted from January 1990 to June 2015… (More)
DOI: 10.1590/0001-3765201620150107

7 Figures and Tables


  • Presentations referencing similar topics